Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Public ClinicalTrials.gov record NCT00594880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00594880
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- The Wistar Institute
- Other
- Enrollment
- 23 participants
Conditions and interventions
Conditions
Interventions
- Pegylated Interferon-alpha 2a, 180 mcg/week sc Drug
- Pegylated Interferon-alpha 2a, 90 mcg/week sc Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Oct 31, 2010
- Completion
- Apr 30, 2011
- Last update posted
- Feb 9, 2015
2008 – 2011
United States locations
- U.S. sites
- 5
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Drexel University College of Medicine | Philadelphia | Pennsylvania | 19102 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Penn-Presbyterian Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| The Wistar Institute | Philadelphia | Pennsylvania | 19104 | — |
| Jonathan Lax Immune Disorders Clinic | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00594880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2015 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00594880 live on ClinicalTrials.gov.